We are developing a nanoparticle gene therapy. Our technology is capable of delivering any nucleic acid. Our primary area of focus is the lung for cystic fibrosis. We are pre-clinical and have good data in a variety of cell lines and animals. We have delivered different types of genes to different cell types, including primary cells collected from the lungs of CF patients.
Company Details
- Founded
- 2017
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.loxegen.net
- Keywords
- Rome.
Loxegen Questions
Loxegen's website is http://www.loxegen.net
Loxegen's LinkedIn profile is https://www.linkedin.com/company/loxegen
Loxegen's industry is
Biotechnology Research
Loxegen's top competitors are
Rnx Lawyers,
Pearce Ip,
Tin Alley Ventures,
Node.vc,
Eir Ventures,
Ventac Partners,
Cube Labs,
Erythrosight,
Ip Group Plc,
Wintermute Biomedical Pty Ltd.
Loxegen's categories are Biotechnology Research
Loxegen's founding year is 2017
